B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers
ConditionCutaneous Squamous Cell Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSohag University
About this trial
Examine the role of B-catenin in differentiation of cutaneous squamous cell carcinoma from other lesions that may be similar to it
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
tissue blocks with sufficient materials Cases with sufficient data
Disqualifiers
tissue blocks with insufficient and necrotic materials. Casas with insufficient data
Trial population
archived formalin fixed parrafin embedded tissue pieces of patients of cutanous squamous cell carcinoma and its mimickers admitted to sohag University hospital from period juniory 2023 to June 2024
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Immunohistochemical staining
Biological/VaccineStaining of cutanous squamous cell carcinoma and its mimickers by monoclonal antibodies against human B-catenin by immunohistochemical procedures
Treatment groups
50 Participants
are divided into 1 treatment groupGroup A: Participants1 intervention
Trial outcomes
Primary outcomes
1
Detection of B-catenin expression in cutanous squamous cell carcinoma and its mimickers
Detection of expression of B-catenin in cutaneous squamous cell carcinoma and its mimickers by immunohistochemical procedures using antihuman B-catenin monoclonal antibodies
Time frame
6 monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov